IJNRD Research Journal

Click Here

WhatsApp editor@ijnrd.org
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 8

Issue Published : 84

Article Submitted : 17592

Article Published : 5245

Total Authors : 13542

Total Reviewer : 835

Total Countries : 129

Indexing Partner

Join RMS/Earn 300


This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: A Review Article On Asthma
Authors Name: Majid Mukhtar , Firdous Ahmed , Omer Fakhereldeen , H.C Patil , Avneet Garg
Download E-Certificate: Download
Author Reg. ID:
Published Paper Id: IJNRD2207084
Published In: Volume 7 Issue 7, July-2022
Abstract: Asthma is a heterogenic disorder that is poorly understood and undertreated, despite the fact that effective treatments and the analytical tools necessary to understand it are both readily available. To effectively treat patients with recurrent nasal or sinus irritation, suppliers must have a working understanding of asthma. The foundation of this article focuses on the present aetiology of asthma, including its definition, potential causes, explosive characteristics, pathophysiology, subtypes, and associated disorders. Despite the fact that asthma affects roughly 8% of adults, the majority of these people have a mild to moderate infection that is treatable with the right care. Considering that, it is estimated that 5–10% of asthmatics have severe infections that are difficult to treat. Therapeutics, including corticosteroids.
Keywords: Asthma, Pathophysiology, Treatment
Cite Article: "A Review Article On Asthma", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 7, page no.687-693, July-2022, Available :http://www.ijnrd.org/papers/IJNRD2207084.pdf
Downloads: 000111419
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2207084
Registration ID: 182098
Published In: Volume 7 Issue 7, July-2022
DOI (Digital Object Identifier):
Page No: 687-693
Country: Bathinda, Punjab, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2207084
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2207084
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)

Providing A digital object identifier by DOI
How to Get DOI? DOI


Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media


This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300